Zacks Research Issues Pessimistic Outlook for IDEX Earnings

IDEX Corporation (NYSE:IEX) – Analysts at Zacks Research lowered their Q1 2027 EPS estimates for shares of IDEX in a report released on Wednesday, April 22nd. Zacks Research analyst Team now expects that the industrial products company will earn $2.00 per share for the quarter, down from their previous estimate of $2.03. The consensus estimate for IDEX’s current full-year earnings is $8.23 per share. Zacks Research also issued estimates for IDEX’s Q2 2027 earnings at $2.37 EPS, Q3 2027 earnings at $2.31 EPS, Q4 2027 earnings at $2.29 EPS, FY2027 earnings at $8.98 EPS, Q1 2028 earnings at $2.28 EPS and FY2028 earnings at $10.00 EPS.

A number of other research firms have also weighed in on IEX. Weiss Ratings reissued a “hold (c)” rating on shares of IDEX in a research report on Monday. Oppenheimer reissued an “outperform” rating and issued a $230.00 price objective on shares of IDEX in a research report on Thursday, February 5th. Argus raised shares of IDEX from a “hold” rating to a “buy” rating and set a $240.00 price objective on the stock in a research report on Friday, February 6th. Stifel Nicolaus reduced their price objective on shares of IDEX from $244.00 to $241.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. Finally, BMO Capital Markets started coverage on shares of IDEX in a research report on Friday, March 27th. They issued a “market perform” rating and a $214.00 price objective on the stock. Six equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $228.90.

IDEX Stock Performance

IDEX stock opened at $206.82 on Thursday. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.86 and a quick ratio of 2.02. IDEX has a 1-year low of $157.25 and a 1-year high of $217.15. The firm has a market capitalization of $15.38 billion, a P/E ratio of 32.27, a price-to-earnings-growth ratio of 2.06 and a beta of 0.99. The company’s 50-day moving average is $198.87 and its 200 day moving average is $186.19.

IDEX (NYSE:IEX) last announced its earnings results on Wednesday, February 4th. The industrial products company reported $2.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.04 by $0.06. The firm had revenue of $899.10 million for the quarter, compared to analysts’ expectations of $882.00 million. IDEX had a net margin of 13.98% and a return on equity of 15.03%. The business’s revenue was up 4.2% compared to the same quarter last year. During the same period in the prior year, the company earned $2.04 EPS. IDEX has set its Q1 2026 guidance at 1.730-1.780 EPS and its FY 2026 guidance at 8.150-8.35 EPS.

Hedge Funds Weigh In On IDEX

A number of hedge funds have recently added to or reduced their stakes in IEX. GoalVest Advisory LLC bought a new position in IDEX in the 4th quarter worth about $26,000. Laurel Wealth Advisors LLC bought a new position in IDEX in the 4th quarter worth about $27,000. SJS Investment Consulting Inc. grew its stake in IDEX by 104.1% in the 1st quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock worth $28,000 after acquiring an additional 76 shares in the last quarter. UMB Bank n.a. grew its stake in IDEX by 61.0% in the 3rd quarter. UMB Bank n.a. now owns 198 shares of the industrial products company’s stock worth $32,000 after acquiring an additional 75 shares in the last quarter. Finally, Cromwell Holdings LLC grew its stake in IDEX by 41.1% in the 4th quarter. Cromwell Holdings LLC now owns 199 shares of the industrial products company’s stock worth $35,000 after acquiring an additional 58 shares in the last quarter. 97.96% of the stock is currently owned by institutional investors.

Trending Headlines about IDEX

Here are the key news stories impacting IDEX this week:

• Neutral Sentiment: Transcript posted of IDEX’s Q2 2025 earnings call — useful for detail and management comments but not new guidance; unlikely to move the stock materially by itself. IDEX (IEX) Q2 2025 Earnings Call Transcript
• Negative Sentiment: Zacks analysts have trimmed multiple near-term and multi-year EPS forecasts for IEX (small downward adjustments across Q1–Q4 FY2027 and FY2028), and a Zacks preview notes IDEX “doesn’t possess the right combination” of factors for a likely earnings beat next week — this creates downside risk to sentiment and could cap near-term upside if the company misses. Idex (IEX) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release
• Negative Sentiment: A Seeking Alpha piece argues IDEX’s valuation looks stretched even given strong growth prospects — a narrative that can pressure multiples and make the stock sensitive to any execution slips or analyst cuts. IDEX Corporation’s Valuation Is Too High Even With Strong Growth

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.